加《医学邮报》第17卷第12期(1981年)报道华盛顿消息:美国食品和药物管理局(FDA)进行的一项研究发现,一种称为甲基氯乙环己亚硝脲(CCNU)的抗癌药能引起肾功能衰竭。国立癌症研究所(NCI)对此项研究结果积压了10个月,才通知美国医生。 NCI是在国会调查科学的诈欺和不端行为的委员会上,听取证词时被人公开揭发的。FDA目前将决定是否停止各种试验,并禁止研究人员为政府进行另一项临床研究。药物已用于数以千计的病人。据报告,癌 Plus Medical Journal Vol. 17, No. 12 (1981) Washington, DC: A study conducted by the U.S. Food and Drug Administration (FDA) found that a compound known as Methylchloride CCNU) can cause kidney failure. The National Cancer Institute (NCI) backlogged the study for 10 months before informing a U.S. physician. The NCI was publicly disclosed during a congressional inquiry into scientific fraud and misconduct commissions. The FDA will now decide whether to stop the trials and ban researchers from conducting another clinical study for the government. Drugs have been used in thousands of patients. According to the report, cancer